Saw Palmetto: Clinical Evidence & Substantiation Summary
What Is Saw Palmetto?
Saw palmetto (Serenoa repens) is a palm plant extract widely used for prostate and urinary health support. It is one of the most studied botanicals for men's health, with evidence primarily supporting urinary symptom management.
Mechanism of action: Saw palmetto inhibits both isoforms of 5-alpha-reductase, reducing conversion of testosterone to dihydrotestosterone (DHT). It also exhibits anti-inflammatory effects via inhibition of COX-2 and 5-LOX pathways, and has anti-proliferative effects on prostatic tissue.
Clinical Evidence Summary
Below are 5 key clinical studies on Saw Palmetto. Nutra Comp analyses 34+ studies in its full clinical evidence report.
Saw palmetto for benign prostatic hyperplasia: updated Cochrane review
Population: 27 RCTs, 5,222 men
Key finding: Saw palmetto (320 mg lipophilic extract) showed modest improvements in urinary symptom scores (IPSS), though results were mixed across studies.
Saw palmetto and lower urinary tract symptoms: meta-analysis
Population: 12 RCTs
Key finding: Saw palmetto significantly improved peak urinary flow rate (WMD: 1.02 mL/s, p=0.03) and nocturia frequency.
Saw palmetto extract and DHT: mechanism review
Population: Clinical and preclinical studies
Key finding: Saw palmetto inhibited 5-alpha-reductase activity in human prostate tissue and reduced serum DHT levels in clinical studies.
Safety of long-term saw palmetto supplementation
Population: 15 studies (1–3 years)
Key finding: Long-term saw palmetto use maintained a favourable safety profile with side effect rates comparable to placebo.
Combination phytotherapy for prostate health
Population: 225 men
Key finding: Saw palmetto combined with lycopene and selenium showed additive benefits for urinary symptoms vs. saw palmetto alone (p=0.03).
Evidence-Based Structure–Function Claims
Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.
Get the full substantiation report for Saw Palmetto
Includes all 34+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.
Join Waitlist for Full AccessRelated Ingredients
Key Terms
Frequently Asked Questions
Is saw palmetto FDA approved?
Saw palmetto is sold as a dietary supplement in the US and does not require FDA approval. In Europe, standardised extracts (e.g., Permixon) are approved as herbal medicines.
What are the most studied benefits?
The strongest evidence supports saw palmetto for prostate health, urinary symptom management, and DHT modulation.
What dosage is used?
The standard dose is 320 mg/day of a lipophilic (fat-soluble) extract, standardised to 85–95% fatty acids and sterols.
Stop Spending Weeks on Substantiation
Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.
Join the Waitlist